Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Optimizing IgAN Care: Sparsentan’s Role Amid the Latest KDIGO Guideline Updates
Jürgen Floege, MD
The Critical Interplay: CKD, HF, and Hyperkalemia
James Burton, DM, FRCP
Javed Butler, MD
Ellie Kelepouris, MD, FACP, FAHA
Patrick Rossignol, MD, PhD
Case-Based Application: Optimizing RAASi/MRA Therapy with Potassium Binders
Guidelines Update: RAASi/MRA Therapy in CKD and HF Management
Javed Butler, MD, MPH, MBA
Implementing Potassium Binders: Practical Dosing and Long-Term Follow Up
Treatment Revolution in IgA Nephropathy
Shikha Wadhwani, MD
Dana Rizk, MD
Optimizing RAASi/MRA Therapy in Patients with Heart Failure, CKD, and Hyperkalemia: A Microlearning Curriculum Approach
Future Directions in Managing Hyperkalemia in CKD and HF
Optimizing Hyperkalemia Management: Clinical Implications and Risk Assessment
Oral Potassium Binders: A Novel Approach to Curb Hyperkalemia in CKD and HF
Potassium Binders in Practice: Clinical Trial Evidence
Potassium Binders: Safety Comes First!
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Difelikefalin: Managing CKD-aP for Improved Quality of Life
Jörg Latus, MD
IgA Nephropathy Updates: Evolving Guidelines and Practical Strategies
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We're glad to see you're enjoying Global Kidney Academy… but how about a more personalized experience?
Press cancel to remain on Global Kidney Academy. Press the link below or the continue button to keep going.